Bleakley Financial Group »

Bicara Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $481k 31k 15.79

More positions owned by Bleakley Financial Group

Sprott Asset Management Physical Gold An (CEF)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Sprott Asset Management Physical Gold Tr (PHYS)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Bleakley Financial Group

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics